Evidence map›Paper›PMID 42876691›Full record

ArticleFrontiers in neurology2026

Baocheng Liu, Ning Wang, Weiwei Kong, Yirong Zhu, Jiaxi You, Yanlin Zhang, Yizhen Shi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Baocheng Liu *Department of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Ning Wang *Department of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Weiwei KongDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yirong ZhuDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Jiaxi YouDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yanlin ZhangDepartment of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Yizhen ShiDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To investigate the correlation of Methods: We retrospectively analyzed 35 AE patients who underwent Results: Among the 35 AE patients (21 males, 14 females), 16 were classified as mild and 19 as moderate-to-severe. Compared to the mild group, the moderate-to-severe group exhibited significantly elevated neutrophil percentages and neutrophil-to-lymphocyte ratio (NLR), alongside reduced lymphocyte percentages, lymphocyte counts, and serum calcium ion levels (Z = -2.75 to 2.30; all Conclusion: In addition to clinical symptoms, specific cerebrospinal fluid and serum biomarkers may help evaluate AE severity.

Indexed as

BrainEncephalitisHashimoto DiseasePositron Emission Tomography Computed TomographyAdultAgedFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesSeverity of Illness IndexFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTautoimmune encephalitisclinical parametersdisease severitymetabolic patterns

Identifiers

PMID42876691
PMCPMC13661387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.